Bio-Path Holdings, Inc. BPTH
We’ve been talking about BPTH all week, after the stock we tagged as a bottom watch play in our morning report on January 23rd had come up from our observed low of 2.65 to nearly the $15-mark. It was an incredible gain indeed, but nothing could have prepared us for what was to come.
Yesterday, following the company’s clinical update on its Phase 2 acute myeloid leukemia drug, prexigebersen, we saw an explosion on the chart that can only be described as the rarest of the rare. BPTH shot up from a daily low of 17.01 to an astounding high of 73.52! That worked out to an intraday swing of 332% As measured from the low following our January alert on the stock, BPTH posted an increase of 2,674% in a matter of just five weeks.
The stock pulled back to the high $30’s following that epic run, so it would appear that the above-mentioned figure will be the final maximum gain on our idea. While this has a chance to go down as our best stock call of the year, the chances that we score bigger gains on options ideas are extremely high. So we encourage any non-subscribers reading this to sign up as soon as possible!
Fresh Options Ideas
Speaking of options, which have also brought us several multi-bag gain opportunities this week, we’ll go ahead and close out this incredibly successful week with a pair of ideas that seem to be good bets here in the premarket. Horrid payroll numbers are contributing to what appears to be an impending bearish day for the markets.
SPY Weekly $274.50-273 Puts*
BIG 03/15 $35-37.50 Calls
*Never trade weekly options on a Friday unless you are an expert level trader with access to disposable funds.
Extended Watchlist:
DSKE, TRIL, SAEX, SEEL, PULM, TROV, TVIX, XXII